Spectral Medical Inc
TSX:EDT

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
TSX:EDT
Watchlist
Price: 0.57 CAD 9.62% Market Closed
Market Cap: 161.2m CAD
Have any thoughts about
Spectral Medical Inc?
Write Note

Intrinsic Value

EDT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one EDT stock under the Base Case scenario is 0.04 CAD. Compared to the current market price of 0.57 CAD, Spectral Medical Inc is Overvalued by 93%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EDT Intrinsic Value
0.04 CAD
Overvaluation 93%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Spectral Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EDT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EDT?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Spectral Medical Inc

Provide an overview of the primary business activities
of Spectral Medical Inc.

What unique competitive advantages
does Spectral Medical Inc hold over its rivals?

What risks and challenges
does Spectral Medical Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Spectral Medical Inc.

Provide P/S
for Spectral Medical Inc.

Provide P/E
for Spectral Medical Inc.

Provide P/OCF
for Spectral Medical Inc.

Provide P/FCFE
for Spectral Medical Inc.

Provide P/B
for Spectral Medical Inc.

Provide EV/S
for Spectral Medical Inc.

Provide EV/GP
for Spectral Medical Inc.

Provide EV/EBITDA
for Spectral Medical Inc.

Provide EV/EBIT
for Spectral Medical Inc.

Provide EV/OCF
for Spectral Medical Inc.

Provide EV/FCFF
for Spectral Medical Inc.

Provide EV/IC
for Spectral Medical Inc.

Show me price targets
for Spectral Medical Inc made by professional analysts.

What are the Revenue projections
for Spectral Medical Inc?

How accurate were the past Revenue estimates
for Spectral Medical Inc?

What are the Net Income projections
for Spectral Medical Inc?

How accurate were the past Net Income estimates
for Spectral Medical Inc?

What are the EPS projections
for Spectral Medical Inc?

How accurate were the past EPS estimates
for Spectral Medical Inc?

What are the EBIT projections
for Spectral Medical Inc?

How accurate were the past EBIT estimates
for Spectral Medical Inc?

Compare the revenue forecasts
for Spectral Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Spectral Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Spectral Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Spectral Medical Inc compared to its peers.

Compare the P/E ratios
of Spectral Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Spectral Medical Inc with its peers.

Analyze the financial leverage
of Spectral Medical Inc compared to its main competitors.

Show all profitability ratios
for Spectral Medical Inc.

Provide ROE
for Spectral Medical Inc.

Provide ROA
for Spectral Medical Inc.

Provide ROIC
for Spectral Medical Inc.

Provide ROCE
for Spectral Medical Inc.

Provide Gross Margin
for Spectral Medical Inc.

Provide Operating Margin
for Spectral Medical Inc.

Provide Net Margin
for Spectral Medical Inc.

Provide FCF Margin
for Spectral Medical Inc.

Show all solvency ratios
for Spectral Medical Inc.

Provide D/E Ratio
for Spectral Medical Inc.

Provide D/A Ratio
for Spectral Medical Inc.

Provide Interest Coverage Ratio
for Spectral Medical Inc.

Provide Altman Z-Score Ratio
for Spectral Medical Inc.

Provide Quick Ratio
for Spectral Medical Inc.

Provide Current Ratio
for Spectral Medical Inc.

Provide Cash Ratio
for Spectral Medical Inc.

What is the historical Revenue growth
over the last 5 years for Spectral Medical Inc?

What is the historical Net Income growth
over the last 5 years for Spectral Medical Inc?

What is the current Free Cash Flow
of Spectral Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Spectral Medical Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Spectral Medical Inc

Current Assets 9.1m
Cash & Short-Term Investments 7.5m
Receivables 352k
Other Current Assets 1.2m
Non-Current Assets 983k
PP&E 799k
Intangibles 184k
Current Liabilities 15m
Accounts Payable 2.8m
Other Current Liabilities 12.3m
Non-Current Liabilities 17.9m
Long-Term Debt 12.6m
Other Non-Current Liabilities 5.3m
Efficiency

Earnings Waterfall
Spectral Medical Inc

Revenue
1.9m CAD
Cost of Revenue
-1.2m CAD
Gross Profit
713k CAD
Operating Expenses
-14.4m CAD
Operating Income
-13.7m CAD
Other Expenses
-4.8m CAD
Net Income
-18.5m CAD

Free Cash Flow Analysis
Spectral Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EDT Profitability Score
Profitability Due Diligence

Spectral Medical Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional ROE
ROE is Increasing
42/100
Profitability
Score

Spectral Medical Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

EDT Solvency Score
Solvency Due Diligence

Spectral Medical Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
27/100
Solvency
Score

Spectral Medical Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EDT Price Targets Summary
Spectral Medical Inc

Wall Street analysts forecast EDT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDT is 2.04 CAD with a low forecast of 2.02 CAD and a high forecast of 2.1 CAD.

Lowest
Price Target
2.02 CAD
254% Upside
Average
Price Target
2.04 CAD
258% Upside
Highest
Price Target
2.1 CAD
268% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EDT?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EDT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Spectral Medical Inc Logo
Spectral Medical Inc

Country

Canada

Industry

Biotechnology

Market Cap

160.3m CAD

Dividend Yield

0%

Description

Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 31 full-time employees. The firm has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin PMX-20R), which is for the treatment of patients with septic shock and endotoxemia that is measured by the Company’s Endotoxin Activity Assay (EAA). EAA and PMX are both Health Canada licensed and commercially available in Canada. The firm through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. SAMI is targeting the acute RRT market, while DIMI is targeting the chronic RRT market.

Contact

ONTARIO
TORONTO
135 - 2 The West Mall
+14166263233.0
www.spectraldx.com

IPO

1992-07-16

Employees

31

Officers

CEO, CFO & Director
Mr. Christopher Seto
Chief Medical Officer
Dr. John A. Kellum M.D.

See Also

Discover More
What is the Intrinsic Value of one EDT stock?

The intrinsic value of one EDT stock under the Base Case scenario is 0.04 CAD.

Is EDT stock undervalued or overvalued?

Compared to the current market price of 0.57 CAD, Spectral Medical Inc is Overvalued by 93%.

Back to Top